Genetic Lipodystrophies

Emery and Rimoin's Principles and Practice of Medical Genetics

Volumn , Issue , 2013, Pages 1-16

  Garg, Abhimanyu ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882761887     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-383834-6.00095-1     Document Type: Chapter

References (125)

1. A. Garg (2004) Acquired and Inherited Lipodystrophies. N. Engl. J. Med. 350 1220-1234.
2. A. Garg (2011) Lipodystrophies: Genetic and Acquired Body Fat Disorders. J. Clin. Endocrinol. Metab. 96 3313-3325.
3. A. Garg and A. Misra (2004) Lipodystrophies: Rare Disorders Causing Metabolic Syndrome. Endocrinol. Metab. Clin. North Am. 33 305-331.
4. Garg, A.; Misra, A. Lipodystrophies and Diabetes. In International Textbook of Diabetes Mellitus; DeFronzo, R. A., Ferrannini, E., Zimmet, P., Eds.; Wiley: New York, 2004; pp 655–672
5. M. Chandalia, A. Garg, F. Vuitch and F. Nizzi (1995) Postmortem Findings in Congenital Generalized Lipodystrophy. J. Clin. Endocrinol. Metab. 80 3077-3081.
6. W.A. Haque, F. Vuitch and A. Garg (2002) Post-Mortem Findings in Familial Partial Lipodystrophy, Dunnigan Variety. Diabet. Med. 19 1022-1025.
7. L.S. Szczepaniak, E.E. Babcock, F. Schick, et al. (1999) Measurement of Intracellular Triglyceride Stores by 1H Spectroscopy: Validation In Vivo. Am. J. Phys. 276 E977-E989.
8. E.A. Oral, V. Simha, E. Ruiz, et al. (2002) Leptin-Replacement Therapy for Lipodystrophy. N. Engl. J. Med. 346 570-578.
9. P.F. Mora, L.C. Ramirez, D. Lender and P. Raskin (1993) Insulin Requirements in Lipodystrophic Diabetes. Diabet. Med. 10 863-865.
10. A. Garg, M. Chandalia and F. Vuitch (1996) Severe Islet Amyloidosis in Congenital Generalized Lipodystrophy. Diabetes Care. 19 28-31.
11. W. Berardinelli (1954) An Undiagnosed Endocrinometabolic Syndrome: Report of 2 Cases. J. Clin. Endocrinol. Metab. 14 193-204.
12. M. Seip (1959) Lipodystrophy and Gigantism with Associated Endocrine Manifestations: A New Diencephalic Syndrome? Acta Paediatr. 48 555-574.
13. J. Magre, M. Delepine, E. Khallouf, et al. (2001) Identification of the Gene Altered in Berardinelli–Seip Congenital Lipodystrophy on Chromosome 11q13. Nat. Genet. 28 365-370.
14. K.B. Gomes, A.P. Fernandes, A.C. Ferreira, et al. (2004) Mutations in the Seipin and AGPAT2 Genes Clustering in Consanguineous Families with Berardinelli–Seip Congenital Lipodystrophy from Two Separate Geographical Regions of Brazil. J. Clin. Endocrinol. Metab. 89 357-361.
15. J.L. Fleckenstein, A. Garg, F.J. Bonte, M.F. Vuitch and R.M. Peshock (1992) The Skeleton in Congenital, Generalized Lipodystrophy: Evaluation Using Whole-Body Radiographic Surveys, Magnetic Resonance Imaging and Technetium-99m Bone Scintigraphy. Skeletal Radiol. 21 381-386.
16. M. Seip and O. Trygstad (1996) Generalized Lipodystrophy, Congenital and Acquired (Lipoatrophy). Acta Paediatr. Suppl. 413 2-28.
17. A.K. Agarwal, E. Arioglu, S. de Almeida, et al. (2002) AGPAT2 Is Mutated in Congenital Generalized Lipodystrophy Linked to Chromosome 9q34. Nat. Genet. 31 21-23.
18. A.K. Agarwal, V. Simha, E.A. Oral, et al. (2003) Phenotypic and Genetic Heterogeneity in Congenital Generalized Lipodystrophy. J. Clin. Endocrinol. Metab. 88 4840-4847.
19. L. Van Maldergem, J. Magre, T.E. Khallouf, et al. (2002) Genotype–Phenotype Relationships in Berardinelli–Seip Congenital Lipodystrophy. J. Med. Genet. 39 722-733.
20. W.A. Haque, I. Shimomura, Y. Matsuzawa and A. Garg (2002) Serum Adiponectin and Leptin Levels in Patients with Lipodystrophies. J. Clin. Endocrinol. Metab. 87 2395-2398.
21. A. Garg, R. Wilson, R. Barnes, et al. (1999) A Gene for Congenital Generalized Lipodystrophy Maps to Human Chromosome 9q34. J. Clin. Endocrinol. Metab. 84 3390-3394.
22. C.A. Kim, M. Delepine, E. Boutet, et al. (2008) Association of a Homozygous Nonsense Caveolin-1 Mutation with Berardinelli–Seip Congenital Lipodystrophy. J. Clin. Endocrinol. Metab. 93 1129-1134.
23. Y.K. Hayashi, C. Matsuda, M. Ogawa, et al. (2009) Human PTRF Mutations Cause Secondary Deficiency of Caveolins Resulting in Muscular Dystrophy with Generalized Lipodystrophy. J. Clin. Invest. 119 2623-2633.
24. D.W. Leung (2001) The Structure and Functions of Human Lysophosphatidic Acid Acyltransferases. Front. Biosci. 6 d944-d953.
25. D. Li, L. Yu, H. Wu, et al. (2003) Cloning and Identification of the Human LPAAT-Zeta Gene, a Novel Member of the Lysophosphatidic Acid Acyltransferase Family. J. Hum. Genet. 48 438-442.
26. A.K. Agarwal and A. Garg (2003) Congenital Generalized Lipodystrophy: Significance of Triglyceride Biosynthetic Pathways. Trends Endocrinol. Metab. 14 214-221.
27. J. West, C.K. Tompkins, N. Balantac, et al. (1997) Cloning and Expression of Two Human Lysophosphatidic Acid Acyltransferase cDNAs that Enhance Cytokine-Induced Signaling Responses in Cells. DNA Cell Biol. 16 691-701.
28. T.M. Lewin, P. Wang and R.A. Coleman (1999) Analysis of Amino Acid Motives Diagnostic for the Sn-Glycerol-3-Phosphate Acyltransferase Reaction. Biochemistry 38 5764-5771.
29. W. Haque, A. Garg and A.K. Agarwal (2005) Enzymatic Activity of Naturally Occurring 1-Acylglycerol-3-Phosphate-O-Acyltransferase 2 Mutants Associated with Congenital Generalized Lipodystrophy. Biochem. Biophys. Res. Commun. 327 446-453.
30. A.K. Agarwal and A. Garg (2004) Seipin: A Mysterious Protein. Trends Mol. Med. 10 440-444.
31. C. Windpassinger, M. Auer-Grumbach, J. Irobi, et al. (2004) Heterozygous Missense Mutations in BSCL2 Are Associated with Distal Hereditary Motor Neuropathy and Silver Syndrome. Nat. Genet. 36 271-276.
32. K.M. Szymanski, D. Binns, R. Bartz, et al. (2007) The Lipodystrophy Protein Seipin Is Found at Endoplasmic Reticulum Lipid Droplet Junctions and Is Important for Droplet Morphology. Proc. Natl. Acad. Sci. U.S.A. 104 20890-20895.
33. W. Fei, G. Shui, B. Gaeta, et al. (2008) Fld1p, A Functional Homologue of Human Seipin, Regulates the Size of Lipid Droplets in Yeast. J. Cell Biol. 180 473-482.
34. V.A. Payne, N. Grimsey, A. Tuthill, et al. (2008) The Human Lipodystrophy Gene BSCL2/Seipin May Be Essential for Normal Adipocyte Differentiation. Diabetes 57 2055-2060.
35. A. Garg and A.K. Agarwal (2008) Caveolin-1: A New Locus for Human Lipodystrophy. J. Clin. Endocrinol. Metab. 93 1183-1185.
36. V. Simha and A. Garg (2003) Phenotypic Heterogeneity in Body Fat Distribution in Patients with Congenital Generalized Lipodystrophy Due to Mutations in the AGPAT2 or Seipin Genes. J. Clin. Endocrinol. Metab. 88 5433-5437.
37. A. Garg, J.L. Fleckenstein, R.M. Peshock and S.M. Grundy (1992) Peculiar Distribution of Adipose Tissue in Patients with Congenital Generalized Lipodystrophy. J. Clin. Endocrinol. Metab. 75 358-361.
38. S. Shastry, M.R. Delgado, E. Dirik, M. Turkmen, A.K. Agarwal and A. Garg (2010) Congenital Generalized Lipodystrophy, Type 4 (CGL4) Associated with Myopathy Due to Novel PTRF Mutations. Am. J. Med. Genet. A 152A 2245-2253.
39. A. Rajab, V. Straub, L.J. McCann, et al. (2010) Fatal Cardiac Arrhythmia and Long-QT Syndrome in a New Form of Congenital Generalized Lipodystrophy with Muscle Rippling (CGL4) Due to PTRF-CAVIN Mutations. PLoS. Genet. 6 e1000874.
40. V. Simha, A.K. Agarwal, P.A. Aronin, S.T. Iannaccone and A. Garg (2008) Novel Subtype of Congenital Generalized Lipodystrophy Associated with Muscular Weakness and Cervical Spine Instability. Am. J. Med. Genet. A 146A 2318-2326.
41. V. Simha and A. Garg (2002) Body Fat Distribution and Metabolic Derangements in Patients with Familial Partial Lipodystrophy Associated with Mandibuloacral Dysplasia. J. Clin. Endocrinol. Metab. 87 776-785.
42. G. Novelli, A. Muchir, F. Sangiuolo, et al. (2002) Mandibuloacral Dysplasia Is Caused by a Mutation in LMNA-Encoding Lamin A/C. Am. J. Hum. Genet. 71 426-431.
43. F. Lin and H.J. Worman (1993) Structural Organization of the Human Gene Encoding Nuclear Lamin A and Nuclear Lamin C. J. Biol. Chem. 268 16321-16326.
44. D.Z. Fisher, N. Chaudhary and G. Blobel (1986) cDNA Sequencing of Nuclear Lamins A and C Reveals Primary and Secondary Structural Homology to Intermediate Filament Proteins. Proc. Natl. Acad. Sci. U.S.A. 83 6450-6454.
45. B. Burke and C.L. Stewart (2002) Life at the Edge: The Nuclear Envelope and Human Disease. Nat. Rev. Mol. Cell Biol. 3 575-585.
46. J.J. Shen, C.A. Brown, J.R. Lupski and L. Potocki (2003) Mandibuloacral Dysplasia Caused by Homozygosity for the R527H Mutation in Lamin A/C. J. Med. Genet. 40 854-857.
47. H. Cao and R.A. Hegele (2003) LMNA Is Mutated in Hutchinson-Gilford Progeria (MIM 176670) but not in Wiedemann–Rautenstrauch Progeroid Syndrome (MIM 264090). J. Hum. Genet. 48 271-274.
48. M. Plasilova, C. Chattopadhyay, P. Pal, et al. (2004) Homozygous Missense Mutation in the Lamin A/C Gene Causes Autosomal Recessive Hutchinson–Gilford Progeria Syndrome. J. Med. Genet. 41 609-614.
49. A.M. Pendas, Z. Zhou, J. Cadinanos, et al. (2002) Defective Prelamin A Processing and Muscular and Adipocyte Alterations in Zmpste24 Metalloproteinase-Deficient Mice. Nat. Genet. 31 94-99.
50. M.O. Bergo, B. Gavino, J. Ross, et al. (2002) Zmpste24 Deficiency in Mice Causes Spontaneous Bone Fractures, Muscle Weakness, and a Prelamin A Processing Defect. Proc. Natl. Acad. Sci. U.S.A. 99 13049-13054.
51. A.K. Agarwal, J.P. Fryns, R.J. Auchus and A. Garg (2003) Zinc Metalloproteinase, ZMPSTE24, Is Mutated in Mandibuloacral Dysplasia. Hum. Mol. Genet. 12 1995-2001.
52. M. Sinensky, K. Fantle, M. Trujillo, T. McLain, A. Kupfer and M. Dalton (1994) The Processing Pathway of Prelamin A. J. Cell Sci. 107(Pt 1), 61-67.
53. L.G. Fong, J.K. Ng, M. Meta, et al. (2004) Heterozygosity for Lmna Deficiency Eliminates the Progeria-Like Phenotypes in Zmpste24-Deficient Mice. Proc. Natl. Acad. Sci. U.S.A. 101 18111-18116.
54. A. Garg, M.D. Hernandez, A.B. Sousa, et al. (2010) An Autosomal Recessive Syndrome of Joint Contractures, Muscular Atrophy, Microcytic Anemia, and Panniculitis-Associated Lipodystrophy. J. Clin. Endocrinol. Metab. 95 E58-E63.
55. A. Horikoshi, S. Iwabuchi, Y. Iizuka, T. Hagiwara and I. Amaki (1980) A Case of Partial Lipodystrophy with Erythema, Dactylic Deformities, Calcification of the Basal Ganglia, Immunological Disorders and Low IQ Level (Author’s Transl). Rinsho Shinkeigaku—Clinical Neurology 20 173-180.
56. M. Tanaka, N. Miyatani, S. Yamada, et al. (1993) Hereditary Lipo-Muscular Atrophy with Joint Contracture, Skin Eruptions and Hyper-Gamma-Globulinemia: A New Syndrome. Intern. Med. 32 42-45.
57. A.K. Agarwal, C. Xing, G.N. DeMartino, et al. (2010) PSMB8 Encoding the Beta5i Proteasome Subunit Is Mutated in Joint Contractures, Muscle Atrophy, Microcytic Anemia, and Panniculitis-Induced Lipodystrophy Syndrome. Am. J. Hum. Genet. 87 866-872.
58. A.J. Rivett and A.R. Hearn (2004) Proteasome Function in Antigen Presentation: Immunoproteasome Complexes, Peptide Production, and Interactions with Viral Proteins. Curr. Protein Pept. Sci. 5 153-161.
59. A. Kitamura, Y. Maekawa, H. Uehara, et al. (2011) A Mutation in the Immunoproteasome Subunit PSMB8 Causes Autoinflammation and Lipodystrophy in Humans. J. Clin. Invest. 121 4150-4160.
60. K. Arima, A. Kinoshita, H. Mishima, et al. (2011) Proteasome Assembly Defect Due to a Proteasome Subunit Beta Type 8 (PSMB8) Mutation Causes the Autoinflammatory Disorder, Nakajo–Nishimura Syndrome. Proc. Natl. Acad. Sci. U.S.A. 108 14914-14919.
61. A. Torrelo, S. Patel, I. Colmenero, et al. (2010) Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature (CANDLE) Syndrome. J. Am. Acad. Dermatol. 62 489-495.
62. Y. Ramot, T. Czarnowicki, A. Maly, P. Navon-Elkan and A. Zlotogorski (2010) Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature Syndrome: A Case Report. Pediatr. Dermatol. epub ahead of print
63. Y. Liu, Y. Ramot, A. Torrelo, et al. (2011) Mutations in PSMB8 Cause CANDLE Syndrome with Evidence of Genetic and Phenotypic Heterogeneity. Arthritis. Rheum.
64. O. Rubio-Cabezas, V. Puri, I. Murano, et al. (2009) Partial Lipodystrophy and Insulin Resistant Diabetes in a Patient with a Homozygous Nonsense Mutation in CIDEC. EMBO Mol. Med. 1 280-287.
65. N. Nishino, Y. Tamori, S. Tateya, et al. (2008) FSP27 Contributes to Efficient Energy Storage in Murine White Adipocytes by Promoting the Formation of Unilocular Lipid Droplets. J. Clin. Invest. 118 2808-2821.
66. J.A. Sensenbrenner, I.E. Hussels and L.S. Levin (1975) CC—A Low Birthweight Syndrome, Rieger Syndrome. Birth Defects 11 423-426.
67. R.J. Gorlin, J. Cervenka, K. Moller, M. Horrobin and J. Witkop (1975) Rieger Anomaly and Growth Retardation (The S-H-O-R-T Syndrome). Birth Defects 11 46-48.
68. G. Sorge, M. Ruggieri, A. Polizzi, A. Scuderi and M. Di Pietro (1996) SHORT Syndrome: A New Case with Probable Autosomal Dominant Inheritance. Am. J. Med. Genet. 61 178-181.
69. A. Bankier, C.G. Keith and I.K. Temple (1995) Absent Iris Stroma, Narrow Body Build and Small Facial Bones: A New Association or Variant of SHORT Syndrome? Clin. Dysmorphol. 4 304-312.
70. D. Aarskog, L. Ose, H. Pande and N. Eide (1983) Autosomal Dominant Partial Lipodystrophy Associated with Rieger Anomaly, Short Stature, and Insulinopenic Diabetes. Am. J. Med. Genet. 15 29-38.
71. S. Shastry, V. Simha and K. Godbole (2010) A Novel Syndrome of Mandibular Hypoplasia, Deafness, and Progeroid Features Associated with Lipodystrophy, Undescended Testes, and Male Hypergonadism. J. Clin. Endocrinol. Metab. 95 E192-E197.
72. T. Rautenstrauch, F. Snigula, T. Krieg, S. Gay and P.K. Muller (1971) Progeria: A Cell Culture Study and Clinical Report of Familial Incidence. Eur. J. Pediatr. 124 101-111.
73. H.R. Wiedemann (1979) An Unidentified Neonatal Progeroid Syndrome: Follow-Up Report. Eur. J. Pediatr. 130 65-70.
74. E.K. Pivnick, B. Angle, R.A. Kaufman, et al. (2000) Neonatal Progeroid (Wiedemann–Rautenstrauch) Syndrome: Report of Five New Cases and Review. Am. J. Med. Genet. 90 131-140.
75. L. Korniszewski, R. Nowak, E. Okninska-Hoffmann, A. Skorka, D. Gieruszczak-Bialek and M. Sawadro-Rochowska (2001) Wiedemann–Rautenstrauch (Neonatal Progeroid) Syndrome: New Case with Normal Telomere Length in Skin Fibroblasts. Am. J. Med. Genet. 103 144-148.
76. T. Hoppen, A. Naumann, U. Theile and M. Rister (2004) Siblings with Neonatal Progeroid Syndrome (Wiedemann–Rautenstrauch). Klin. Padiatr. 216 70-71.
77. F. Thorey, M. Jager, K. Seller, R. Krauspe and A. Wild (2003) Kyphoscoliosis in Wiedemann–Rautenstrauch Syndrome (Neonatal Progeroid Syndrome). Z. Orthop. Ihre. Grenzgeb. 141 341-344.
78. F.L. Ozer, J.R. Lichtenstein, P.O. Kwiterovich and V.A. McKusick (1973) A New Genetic Variety of Lipodystrophy. Clin. Res. 21 533. (abstract)
79. M.G. Dunnigan, M.A. Cochrane, A. Kelly and J.W. Scott (1974) Familial Lipoatrophic Diabetes with Dominant Transmission. A New Syndrome. Q. J. Med. 43 33-48.
80. A. Garg (2000) Gender Differences in the Prevalence of Metabolic Complications in Familial Partial Lipodystrophy (Dunnigan Variety). J. Clin. Endocrinol. Metab. 85 1776-1782.
81. A. Garg (2000) Lipodystrophies. Am. J. Med. 108 143-152.
82. A. Garg, R.M. Peshock and J.L. Fleckenstein (1999) Adipose Tissue Distribution in Patients with Familial Partial Lipodystrophy (Dunnigan Variety). J. Clin. Endocrinol. Metab. 84 170-174.
83. W.A. Haque, E.A. Oral, K. Dietz, A.M. Bowcock, A.K. Agarwal and A. Garg (2003) Risk Factors for Diabetes in Familial Partial Lipodystrophy, Dunnigan Variety. Diabetes Care 26 1350-1355.
84. R.A. Hegele (2001) Premature Atherosclerosis Associated with Monogenic Insulin Resistance. Circulation 103 2225-2229.
85. A. Garg, R.A. Speckman and A.M. Bowcock (2002) Multisystem Dystrophy Syndrome Due to Novel Missense Mutations in the Amino-Terminal Head and Alpha-Helical Rod Domains of the Lamin A/C Gene. Am. J. Med. 112 549-555.
86. J.M. Peters, R. Barnes, L. Bennett, W.M. Gitomer, A.M. Bowcock and A. Garg (1998) Localization of the Gene for Familial Partial Lipodystrophy (Dunnigan Variety) to Chromosome 1q21–22. Nat. Genet. 18 292-295.
87. H. Cao and R.A. Hegele (2000) Nuclear Lamin A/C R482Q Mutation in Canadian Kindreds with Dunnigan-Type Familial Partial Lipodystrophy. Hum. Mol. Genet. 9 109-112.
88. R.A. Speckman, A. Garg, F. Du, et al. (2000) Mutational and Haplotype Analyses of Families with Familial Partial Lipodystrophy (Dunnigan Variety) Reveal Recurrent Missense Mutations in the Globular C-Terminal Domain of Lamin A/C. Am. J. Hum. Genet. 66 1192-1198.
89. S. Shackleton, D.J. Lloyd, S.N. Jackson, et al. (2000) LMNA, Encoding Lamin A/C, Is Mutated in Partial Lipodystrophy. Nat. Genet. 24 153-156.
90. G. Bonne, M.R. Di Barletta, S. Varnous, et al. (1999) Mutations in the Gene Encoding Lamin A/C Cause Autosomal Dominant Emery–Dreifus Muscular Dystrophy. Nat. Genet. 21 285-288.
91. M. di Barletta, E. Ricci, G. Galluzzi, et al. (2000) Different Mutations in the LMNA Gene Cause Autosomal Dominant and Autosomal Recessive Emery-Dreifuss Muscular Dystrophy. Am. J. Hum. Genet. 66 1407-1412.
92. A. Muchir, G. Bonne, A.J. van der Kooi, et al. (2000) Identification of Mutations in the Gene Encoding Lamins A/C in Autosomal Dominant Limb Girdle Muscular Dystrophy with Atrioventricular Conduction Disturbances (LGMD1B). Hum. Mol. Genet. 9 1453-1459.
93. M. Eriksson, W.T. Brown, L.B. Gordon, et al. (2003) Recurrent De Novo Point Mutations in Lamin A Cause Hutchinson-Gilford Progeria Syndrome. Nature 423 293-298.
94. L. Chen, L. Lee, B.A. Kudlow, et al. (2003) LMNA Mutations in Atypical Werner’s Syndrome. Lancet 362 440-445.
95. A. De Sandre-Giovannoli, M. Chaouch, S. Kozlov, et al. (2002) Homozygous Defects in LMNA, Encoding Lamin A/C Nuclear-Envelope Proteins, Cause Autosomal Recessive Axonal Neuropathy in Human (Charcot–Marie–Tooth Disorder Type 2) and Mouse. Am. J. Hum. Genet. 70 726-736.
96. C. Vigouroux, C. Bourut, B. Guerci, et al. (2000) A New Missense Mutation in the Calcium-Sensing Receptor in Familial Benign Hypercalcaemia Associated with Partial Lipoatrophy and Insulin Resistant Diabetes. Clin. Endocrinol. 53 393-398.
97. A. Garg, M. Vinaitheerthan, P. Weatherall and A. Bowcock (2001) Phenotypic Heterogeneity in Patients with Familial Partial Lipodystrophy (Dunnigan Variety) Related to the Site of Mis-Sense Mutations in Lamin A/C (LMNA) Gene. J. Clin. Endocrinol Metab. 86 59-65.
98. M.C. Vantyghem, P. Pigny, C.A. Maurage, et al. (2004) Patients with Familial Partial Lipodystrophy of the Dunnigan Type Due to a LMNA R482W Mutation Show Muscular and Cardiac Abnormalities. J. Clin. Endocrinol. Metab. 89 5337-5346.
99. A.K. Agarwal and A. Garg (2002) A Novel Heterozygous Mutation in Peroxisome Proliferator-Activated Receptor-γ Gene in a Patient with Familial Partial Lipodystrophy. J. Clin. Endocrinol. Metab. 87 408-411.
100. R.A. Hegele, H. Cao, C. Frankowski, S.T. Mathews and T. Leff (2002) PPARG F388L, A Transactivation-Deficient Mutant, in Familial Partial Lipodystrophy. Diabetes 51 3586-3590.
101. D.B. Savage, G.D. Tan, C.L. Acerini, et al. (2003) Human Metabolic Syndrome Resulting From Dominant-Negative Mutations in the Nuclear Receptor Peroxisome Proliferator-Activated Receptor-Gamma. Diabetes 52 910-917.
102. K.Z. Al-Shali, A.A. House, A.J. Hanley, et al. (2004) Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor Gamma Associated with Carotid Atherosclerosis. Stroke 35 2036-2040.
103. E.D. Rosen, P. Sarraf, A.E. Troy, et al. (1999) PPAR Gamma Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro. Mol. Cell 4 611-617.
104. C. Knouff and J. Auwerx (2004) Peroxisome Proliferator-Activated Receptor-Gamma Calls for Activation in Moderation: Lessons from Genetics and Pharmacology. Endocr. Rev. 25 899-918.
105. S. George, J.J. Rochford, C. Wolfrum, et al. (2004) A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2. Science 304 1325-1328.
106. B. Vanhaesebroeck and D.R. Alessi (2000) The PI3K-PDK1 Connection: More than Just a Road to PKB. Biochem. J. 346(Pt 3), 561-576.
107. R.S. Garofalo, S.J. Orena, K. Rafidi, et al. (2003) Severe Diabetes, Age-Dependent Loss of Adipose Tissue, and Mild Growth Deficiency in Mice Lacking Akt2/PKB Beta. J. Clin. Invest. 112 197-208.
108. S. Gondotra, C. Le Dour, W. Bottomley, et al. (2011) Perilipin Deficiency and Autosomal Dominant Partial Lipodystrophy. N. Engl. J. Med. 364 740-748.
109. S. Gondotra, K. Lim, A. Girousse, et al. (2011) Human Frame Shift Mutations Affecting the Carboxyl Terminus of Perilipin Increase Lipolysis by Failing to Sequester the Adipose Triglyceride Lipase (ATGL) Coactivator AB-Hydrolase-Containing 5 (ABHD5). J. Biol. Chem. 286 34998-35006.
110. K.L. Herbst, L.R. Tannock, S.S. Deeb, J.Q. Purnell, J.D. Brunzell and A. Chait (2003) Kobberling Type of Familial Partial Lipodystrophy: An Underrecognized Syndrome. Diabetes Care. 26 1819-1824.
111. F. Caux, E. Dubosclard, O. Lascols, et al. (2003) A New Clinical Condition Linked to a Novel Mutation in Lamins A and C with Generalized Lipoatrophy, Insulin-Resistant Diabetes, Disseminated Leukomelanodermic Papules, Liver Steatosis, and Cardiomyopathy. J. Clin. Endocrinol. Metab. 88 1006-1013.
112. K.L. Herbst, L.R. Tannock, S.S. Deeb, et al. (2003) Kobberling Type of Familial Partial Lipodystrophy: an Underrecognized Syndrome. Diabetes Care. 26 1819-1824.
113. R.L. Pollex and R.A. Hegele (2004) Hutchinson–Gilford Progeria Syndrome. Clin. Genet. 66 375-381.
114. M.R. D’Apice, R. Tenconi, I. Mammi, J. van den Ende and G. Novelli (2004) Paternal Origin of LMNA Mutations in Hutchinson–Gilford Progeria. Clin. Genet. 65 52-54.
115. A. De Sandre-Giovannoli, R. Bernard, P. Cau, et al. (2003) Lamin a Truncation in Hutchinson–Gilford Progeria. Science 300 2055.
116. V.C. Pardini, I.M. Victoria, S.M. Rocha, et al. (1998) Leptin Levels, Beta-Cell Function, and Insulin Sensitivity in Families with Congenital and Acquired Generalized Lipoatrophic Diabetes. J. Clin. Endocrinol. Metab. 83 503-508.
117. M. McNally, R.B. Mannon, E.D. Javor, et al. (2004) Successful Renal Transplantation in a Patient with Congenital Generalized Lipodystrophy: A Case Report. Am. J. Transplant. 4 447-449.
118. Z. Ahmad, E. Zackai, L. Medne and A. Garg (2010) Early Onset Mandibuloacral Dysplasia Due to Compound Heterozygous Mutations in ZMPSTE24. Am. J. Med. Genet. A 152A 2703-2710.
119. A.K. Agarwal, X.J. Zhou, R.K. Hall, et al. (2006) Focal Segmental Glomerulosclerosis in Patients with Mandibuloacral Dysplasia Due to Zinc Metalloproteinase Deficiency. J. Investig. Med. 54 208-213.
120. A. Misra and A. Garg (2003) Clinical Features and Metabolic Derangements in Acquired Generalized Lipodystrophy: Case Reports and Review of the Literature. Medicine 82 129-146.
121. Expert Panel on Detection E (2001) Treatment of High Blood Cholesterol in A. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 2486-2497. [see comments]
122. A. Garg and S.M. Grundy (1990) Nicotinic Acid as Therapy for Dyslipidemia in Non-Insulin-Dependent Diabetes Mellitus. JAMA 264 723-726.
123. V. Simha, L.S. Szczepaniak, A.J. Wagner, A.M. DePaoli and A. Garg (2003) Effect of Leptin Replacement on Intrahepatic and Intramyocellular Lipid Content in Patients with Generalized Lipodystrophy. Diabetes Care. 26 30-35.
124. K.F. Petersen, E.A. Oral, S. Dufour, et al. (2002) Leptin Reverses Insulin Resistance and Hepatic Steatosis in Patients with Severe Lipodystrophy. J. Clin. Invest. 109 1345-1350.
125. V. Simha, L. Subramanyam, L. Szczepaniak, et al. (2012) Comparison of Efficacy and Safety of Leptin Replacement Therapy in Moderately and Severely Hypoleptinemic Patients with Familial Partial Lipodystrophy of the Dunnigan Variety. J. Clin. Endocrinol. Metab. 97 785-792.